Skip to content

Application of a nucleophilic substitution rection for spectrofluorimetric quantification of ketamine in pharmaceutical and plasma matrices.

Reem M Alnemari, Maram H Abduljabbar, Yusuf S Althobaiti, Farooq M Almutairi, Muneef M Aldhafeeri, Atiah H Almalki, Sherif Ramzy

Scientific reports December 30, 2024 DOI: 10.1038/s41598-024-82427-2 via PubMed

Summary

AI-generated from the abstract

A new, environmentally friendly spectrofluorimetric method detects ketamine in pharmaceutical and plasma samples with high sensitivity. The method relies on a nucleophilic substitution reaction between ketamine and NBD-Cl, producing a fluorescent derivative measurable at 543 nm emission after 481 nm excitation. Over a concentration range of 10–250 ng/mL, fluorescence intensity correlates linearly with ketamine concentration. Detection and quantitation limits are 2.37 ng/mL and 7.18 ng/mL, respectively. The method is precise (relative standard deviation < 1), accurate (mean recovery 99.74%), and robust (recovery 98.00–99.97%). Compared to existing methods, it is more sensitive and ecologically benign.

Study at a glance

Characteristics Method development and validation Peer reviewed
Topics Ketamine
Keywords Date-rape drug Drug addiction Eco-friendly spectrofluorimetric method Super k Drug detection
Key finding A spectrofluorimetric method using NBD-Cl detects ketamine at concentrations as low as 2.37 ng/mL in pharmaceutical and plasma samples, with high precision, accuracy, and environmental friendliness.

Abstract

Ketamine is a dissociative anesthetic drug that is abused by teenagers and young adults, commonly for recreational purposes in dance clubs, to generate euphoria and dissociation, and sometimes employed as a date-rape drug. Herein, a highly sensitive, and environmentally friendly spectrofluorimetric method was developed for detection of ketamine in pharmaceutical and plasma samples. The technique is based on a nucleophilic substitution reaction occurring between ketamine and NBD-Cl (4-chloro-7-nitrobenzo-2-oxa-1,3-diazole), resulting in the formation of a fluorescent derivative that exhibits detectability at a remarkable level. The resultant derivative demonstrates its maximum emission intensity at 543 nm upon excitation at a wavelength of 481 nm. Upon optimizing the reaction parameters, a linear relationship was established between the fluorescence intensity of the formed derivative and the concentrations of ketamine within the specified range of 10 - 250 ng/mL. The method demonstrated exceptional sensitivity with detection and quantitation limits of 2.37 ng/mL and 7.18 ng/mL, respectively, allowing for the detection of ketamine in both pharmaceutical and plasma samples. The method was precise (%RSD < 1) accurate (%R = 99.74%) and robust (% R ± SD from 98.00 ± 1.11 to 99.97 ± 0.75). Furthermore, the developed method was compared to the reported method, with the results indicating that the suggested method is more sensitive and ecologically benign.

Explore topics

Comments

No comments yet.

Log in to comment